Financial Daily from THE HINDU group of publications
Wednesday, May 11, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Overseas Borrowings


Jubilant to raise $75 m

Our Bureau

NEW DELHI: JUBILANT Organosys Ltd will raise $75 million through a foreign currency convertible bond (FCCB) issue to be listed on the Singapore Stock Exchange.

According to a company statement, the unsecured and zero coupon 5-year FCCB issue has an upsizing option of $25 million. The issue will have a yield to maturity of 6.6 per cent per annum, placed with international investors, it added.

The FCCB has a 50 per cent conversion premium at Rs 1,365.32 a share, the statement said. The share has been hovering around Rs 900.

The company has said that it has already applied for listing the FCCBs on the Singapore Stock Exchange. The proceeds of the issue will be used to fund the capital expenditure for the company's expansion plans, acquisition and any other permitted use, said the company.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Mishap at Premier Explosives


GAIL in talks to buy Indonesian LNG for Dabhol
Amrit Foods to double production capacity of flavoured milk
New Reva to be launched today
Godrej board nod for share buyback
Jubilant to raise $75 m
Kribhco bags NPC award
Birlas move HC seeking intervention
Ecoboard back in black
Malladi Drugs acquires US-based Novus
Bajaj Electricals in pact with US co
Dai Ichi in pact with GVK Bio
Natco tie-up with US varsity
`Family businesses should professionalise management'
LML plans 100 cc bike launch in August
Reliance to maintain export volumes of diesel, petrol at present levels
Maruti's Swift likely to be priced in Rs 4.5 lakh-6.5 lakh range


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line